Wisekey Internat Stock Price, News & Analysis

WISeKey has finalized a $300,000 contract with arago to enhance COVID-19 pandemic management. This marks the company’s second contract within a month, emphasizing its commitment to combat the economic repercussions of the pandemic. The collaboration leverages WISeKey's cybersecurity and identity management technologies to ensure secure data handling for COVID-19 risk assessment. A robust pipeline exceeding $20 million for COVID-19 projects is visible, indicating strong future potential.

WISeKey International Holding Ltd. (NASDAQ: WKEY) announced a webinar on AIoT and Cybersecurity, set for October 12, 2020, at 3:00 pm CET. This event will showcase WIShelter SafePass, an innovative digital identity platform aimed at enhancing eHealth services, including diagnostics and vaccine education. The webinar will discuss disruptive digital technologies for public health during COVID-19, addressing scalability, security, and real-time monitoring of virus spread. Notably, WISeKey's advanced solutions have garnered partnerships with health organizations for AI-based diagnostics, further supporting global health initiatives.

WISeKey International Holding Ltd (NASDAQ: WKEY) has announced the integration of advanced digital security solutions into commercial drones. This technology enhances the security, authenticity, and efficiency of drone operations across industries. The WISeKey VaultIC4xx series ensures secure connections and protects data integrity, certified to high security standards. The demand for secure drone operations is growing, particularly among public safety and defense sectors. This initiative positions WISeKey favorably in the expanding drone market, which faces increasing regulatory oversight.

WISeKey International Holding Ltd has partnered with IoTeX to enhance manufacturing integrity through secure semiconductors and blockchain technology. Announced on September 28, 2020, this collaboration aims to ensure the authenticity and quality of manufacturing processes. By integrating secure hardware with blockchain, they provide immutable traceability and verifiable trust across various industries. A key use case is a blockchain-enabled 3D printer, showcasing the comprehensive tracking of input and process authenticity. The solution will be demonstrated in enterprise forums.

WISeKey has partnered with ClinIQ Inc to use the VirusIQ platform for secure COVID-19 health screening, telemedicine, and diagnostics. This collaboration aims to generate over $2 million in revenue for WISeKey in 2021 and open new market opportunities in healthcare. The WIShelter SafePass will leverage both WISeID and VirusIQ technologies to provide secure medical services and data access. The initiative supports businesses in reopening during the pandemic, focusing on user privacy and security.

WISeKey has opened an Artificial Intelligent of Things (AIoT) Laboratory in Meyreuil, France, focusing on enhancing IoT security. The facility integrates AI, IoT, and Cybersecurity to assess networked devices' security, employing 30 dedicated staff. The lab complies with ISO 27001 certification, offering services like IoT security assessment and penetration testing. WISeKey aims to leverage its extensive experience to attract high-profile clients in the IoT cybersecurity sector, facilitating innovation and reducing operational costs.

WISeKey International Holding (NASDAQ: WKEY) has launched an upgraded version of its INeS Security Broker, enhancing the secure verification of credentials for IoT devices using PKI technologies. The upgraded platform supports functionalities such as activation, revocation, and update management for IoT devices. Notably, WISeKey integrates AI with IoT through its AIoT initiative, enhancing operational capabilities for sectors like automotive, healthcare, and smart cities. The ecosystem currently connects over 1.6 billion IoT devices and is positioned for growth with the advent of 5G technology.

WISeKey has been selected by Digital Diagnostics AG to secure its digid cantisense™ SARS-CoV-2 test. This revolutionary test allows for immediate on-site COVID-19 antigen testing, yielding results in five minutes. The partnership positions WISeKey to capitalize on the growing AIoT market in healthcare, projected to generate over $10 million in revenue in 2021. The integration of AI and IoT technologies enhances data processing and real-time monitoring capabilities, paving the way for innovative healthcare solutions.

WISeKey to Present at H.C. Wainwright Conference

WISeKey International Holding Ltd. (NASDAQ: WKEY) announced that Carlos Moreira, CEO, will present at the H.C. Wainwright Annual Global Investment Virtual Conference on September 16, 2020, at 9:30 am ET. Virtual one-on-one meetings will also be available for investors. Interested parties can register for the presentation at this link. An archived version will be available on WISeKey's website.